Pacific Biosciences stock ahead of November 4 results call
Published on 11/03/2026 at 22:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat PacBio Investors Watch Next
- PacBio will discuss its third-quarter 2026 financial results on November 4.
- The webcast is scheduled for 4:30 p.m. Eastern Time after the U.S. market close.
Pacific Biosciences of California will discuss its third-quarter 2026 financial results on Wednesday, November 4, after the U.S. market close. The company announced the date and webcast details in a PacBio investor release published on October 14.
Results Call Sets Next Investor Checkpoint
The conference call is scheduled for 4:30 p.m. Eastern Time, or 1:30 p.m. Pacific Time. PacBio said the event will be available by webcast, with a replay accessible through its investor website.
The appointment gives investors the next opportunity to assess revenue trends, demand for sequencing systems and consumables, margins, cash use and management's outlook. The release itself did not provide third-quarter financial figures or new guidance.
Late Trading Keeps Shares In Focus
The real-time quote of Pacific Biosciences stock was 2.17 euros on Lang & Schwarz at 10:15 p.m. CET on Tuesday, November 3, 2026.
Pacific Biosciences at a glance
- Company: Pacific Biosciences of California, Inc.
- ISIN: US69404D1081
- Ticker: PACB
- Lang & Schwarz quote: 2.17 euros at 10:15 p.m. CET on November 3, 2026
- Next event: Third-quarter 2026 results call on November 4, 2026, at 4:30 p.m. Eastern Time
For the broader U.S. market, investors can follow current developments in the S&P 500 market reports.
